PHARMA-TRADE A/S
CVR 87339815 · Public limited company (A/S) · Active · Low risk
PHARMA-TRADE A/S is a Public limited company (A/S), founded on , based in Græsted. The company is registered in the industry fremstilling af parfume, hårshampoo, tandpasta mv.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 254.0m and a net result of DKK 21.2m. CEO: Henrik Overgaard.
Bankruptcy risk for PHARMA-TRADE A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 87339815
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (42 years)
- Address
- Skaaremosevej 11
3230 Græsted - Municipality
- Gribskov
- Industry
- Fremstilling af parfume, hårshampoo, tandpasta mv. (204200)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 3.0m
- Employees
- 3 (2018)
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | 355,950% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 6 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 0 | DKK 0 | DKK 0 |
| Gross profit | DKK 0 | DKK 0 | DKK 0 |
| Net profit | DKK 21.2m | DKK 43.1m | DKK 34.4m |
| Equity | DKK 254.0m | DKK 272.8m | DKK 251.4m |
| Total assets | DKK 254.0m | DKK 272.8m | DKK 251.4m |
| Cash | DKK 1.0m | DKK 2.4m | – |
| Short-term debt | DKK 22k | DKK 21k | – |
| Tax owed | DKK 0 | DKK 0 | – |
| Avg. employees | 1 | 0 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 141 | ||
| 1 Jan 2024 – 31 Dec 2024 | 146 | ||
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 151 | ||
| 1 Jan 2021 – 31 Dec 2021 | 122 | ||
| 1 Jan 2020 – 31 Dec 2020 | 147 | ||
| 1 Jan 2019 – 31 Dec 2019 | 244 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 143 | ||
| 1 Jan 2017 – 31 Dec 2017 | 148 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 112 | ||
| 1 Jan 2014 – 31 Dec 2014 | 126 | ||
| 1 Jan 2013 – 31 Dec 2013 | 133 | ||
| 1 Jan 2012 – 31 Dec 2012 | 154 | ||
| 1 Jan 2011 – 31 Dec 2011 | 134 | ||
| 1 Jan 2010 – 31 Dec 2010 | 155 | ||
| 1 Jan 2009 – 31 Dec 2009 | 139 | ||
| 1 Jan 2008 – 31 Dec 2008 | 141 | ||
| 1 Jan 2007 – 31 Dec 2007 | 149 | ||
| 1 Jan 2006 – 31 Dec 2006 | 144 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Henrik Overgaard | Current | |
| CEO | Ib Preben Overgaard | ||
| Board | Henrik Overgaard | Current | |
| Board | Jan Overgaard | Current | |
| Board | Kresten Mikael Valdal | Current | |
| Board | Niels Ebbe Valdal | ||
| Board | Jan Overgaard | ||
| Board | Ib Preben Overgaard | ||
| Owner (50%) | PIF Holding ApS | Current | |
| Owner (50%) | DANYL FINANS A/S | Current | |
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Auditor | GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB |
The CEOs' other companies
Henrik Overgaard – 13 other companies
- DANYL EJENDOMME A/S Fusioneret
- DANYL FINANS A/S Active
- DANYL HOLDING A/S Fusioneret
- DANYL PLASTTEKNIK A/S Active
- Danyl Holding 2021 ApS Fusioneret
- Danyl Holding ApS Active
- EJENDOMSSELSKABET KNUD BRO ALLE 3 ApS Active
- G87 ApS Opløst
- PERPHARMA A/S Fusioneret
- PERSANO GROUP A/S Active
- PERSANO PLAST A/S Fusioneret
- PHARMATRADE EJENDOMME A/S Opløst
- PROPHARMA A/S Fusioneret
Ib Preben Overgaard – 10 other companies
- DANYL EJENDOMME A/S Fusioneret
- DANYL FINANS A/S Active
- DANYL HOLDING A/S Fusioneret
- DANYL PLASTTEKNIK A/S Active
- G87 ApS Opløst
- PERPHARMA A/S Fusioneret
- PERSANO GROUP A/S Active
- PERSANO PLAST A/S Fusioneret
- PHARMATRADE EJENDOMME A/S Opløst
- PROPHARMA A/S Fusioneret
Address history (1 moves)
| Skaaremosevej 11, 3230 Græsted | |
| Skaaremosevej 11, 3230 Græsted |
Former names
| PHARMA-TRADE A/S | – now |
| PHARMATRADE A/S | – |
| FATIMA A/S | – |
Employees per year
Other companies at the same address
- EJENDOMSSELSKABET KNUD BRO ALLE 3 ApS Active
- PERPHARMA A/S Fusioneret
- PERSANO GROUP A/S Active
- PERSANO PLAST A/S Fusioneret
- PHARMATRADE EJENDOMME A/S Opløst
- PROPHARMA A/S Fusioneret
Similar companies in Gribskov
- ILKA ApS Græsted
- PERSANO GROUP A/S Græsted
- Christina Bonde ApS Tisvildeleje
- PROPHARMA A/S Græsted
Questions and answers about PHARMA-TRADE A/S
Has PHARMA-TRADE A/S gone bankrupt?
No, PHARMA-TRADE A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of PHARMA-TRADE A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of PHARMA-TRADE A/S?
Henrik Overgaard is the CEO of PHARMA-TRADE A/S.
Who is the auditor of PHARMA-TRADE A/S?
PHARMA-TRADE A/S most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was PHARMA-TRADE A/S founded?
PHARMA-TRADE A/S was founded on 11 April 1984.
What is the equity of PHARMA-TRADE A/S?
Equity was DKK 254.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.